KCTD21 Inhibitors
KCTD21 inhibitors encompass a variety of chemical compounds that interact with different cellular pathways, ultimately leading to the inhibition of KCTD21. Proteasome inhibitors like MG-132 and Bortezomib function by impeding the degradation of ubiquitinated proteins, potentially leading to the accumulation of inactive, polyubiquitinated forms of KCTD21. On the other hand, lysosomal pH modulators, such as Hydroxychloroquine and Chloroquine, disrupt lysosomal function, which could indirectly impair the degradation or recycling pathways critical for KCTD21 function.
Proteasome Inhibitors such as MG-132 and Bortezomib work by preventing the proteasomal degradation of ubiquitinated proteins. This can lead to an accumulation of proteins within the cell, including potentially inactive, polyubiquitinated forms of KCTD21. The buildup of such proteins can interfere with various cellular functions and may result in the diminished activity of KCTD21 if it is normally targeted for degradation through this pathway.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Hydroxychloroquine is an aminoquinoline compound known to alter lysosomal pH, which can affect lysosome-dependent degradation processes. Since KCTD21 is a protein that may require proper lysosomal function for recycling or degradation, sustained alteration in lysosomal pH by hydroxychloroquine could indirectly inhibit KCTD21's functional cycling within the cell. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a potent proteasome inhibitor that prevents the degradation of ubiquitinated proteins. If KCTD21 is regulated by ubiquitination, proteasome inhibition can lead to its accumulation in its inactive polyubiquitinated form, thus reducing its functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphatidylinositol 3-kinase (PI3K) inhibitor, which prevents the phosphorylation of Akt, thereby inhibiting the PI3K/Akt signaling pathway. If KCTD21 function depends on PI3K/Akt pathway output, inhibition by LY294002 can decrease KCTD21 activity indirectly by reducing signaling through this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK, which is involved in cellular stress responses. If KCTD21 activity is modulated as part of the cellular response to stress and is p38 MAPK-dependent, then inhibition by SB203580 can suppress the functional activity of KCTD21. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor which blocks the MAPK/ERK pathway. If KCTD21 activity is modulated by the MAPK/ERK pathway, MEK inhibition by PD98059 can lead to decreased activation of this pathway and subsequently inhibit KCTD21 function. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
Spautin-1 promotes the degradation of autophagy-related proteins by inhibiting ubiquitin-specific peptidases. If KCTD21 is stabilized by autophagy inhibitors, Spautin-1 could indirectly inhibit KCTD21 by disrupting autophagy processes that protect it from degradation. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Similar to hydroxychloroquine, chloroquine is an antimalarial that affects lysosomal function by increasing lysosomal pH. This can inhibit lysosomal enzymes and may lead to a decrease in the functional recycling or degradation of KCTD21. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a dipeptidyl boronic acid that functions as a proteasome inhibitor. If KCTD21 undergoes regulatory control by ubiquitination, proteasome inhibition by bortezomib could result in an accumulation of inactive KCTD21. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is an irreversible inhibitor of PI3K, which like LY294002, can prevent Akt phosphorylation. Inhibition of the PI3K/Akt pathway by wortmannin could lead to a reduction in KCTD21 activity if it is dependent on this signaling pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which affects cellular growth and metabolism. If KCTD21 function is coupled to mTOR signaling, rapamycin-mediated inhibition could lead to a decrease in KCTD21's activity. | ||||||